These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1153623)

  • 1. Assessment of cerebrospinal fluid levels of dopamine metabolites by gas chromatography.
    Watson E; Wilk S
    Psychopharmacologia; 1975 Apr; 42(1):57-6. PubMed ID: 1153623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of drug-induced changes in dopamine and serotonin metabolite concentrations in the CSF of the rat.
    Mignot E; Laude D; Elghozi JL
    J Neurochem; 1984 Mar; 42(3):819-25. PubMed ID: 6198472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
    Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
    Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14C-homovanillic acid in the cerebrospinal fluid of parkinsonian patients after intravenous 14C-L-dopa.
    Extein I; Van Woert M; Roth RH; Bowers MB
    Biol Psychiatry; 1976 Apr; 11(2):227-32. PubMed ID: 971447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine metabolites in the CSF of conscious unrestrained cats.
    Degrell I; Zenner K; Kummer P; Stock G
    Brain Res; 1983 Oct; 277(2):283-7. PubMed ID: 6196083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
    Andersen AD; Blaabjerg M; Binzer M; Kamal A; Thagesen H; Kjaer TW; Stenager E; Gramsbergen JBP
    J Neurochem; 2017 May; 141(4):614-625. PubMed ID: 28244186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraventricular microdialysis: a new method for determining monoamine metabolite concentrations in the cerebrospinal fluid of freely moving rats.
    Becker JB; Adams F; Robinson TE
    J Neurosci Methods; 1988 Jul; 24(3):259-69. PubMed ID: 2458511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations in human lumbar cerebrospinal fluid.
    Ebinger G; Michotte Y; Herregodts P
    J Neurochem; 1987 Jun; 48(6):1725-9. PubMed ID: 3572399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment.
    Stefani A; Pierantozzi M; Olivola E; Galati S; Cerroni R; D'Angelo V; Hainsworth AH; Saviozzi V; Fedele E; Liguori C
    Neurochem Int; 2017 May; 105():58-63. PubMed ID: 28108196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The estimation of 3,4-dihydroxyphenylacetic acid, homovanillic acid and homo-isovanillic acid in nervous tissue by gas-liquid chromatography and electron capture detection.
    Pearson JD; Sharman DF
    Br J Pharmacol; 1975 Jan; 53(1):143-8. PubMed ID: 164966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF monamine metabolites in movement disorders and normal aging.
    Stahl SM; Faull KF; Barchas JD; Berger PA
    Arch Neurol; 1985 Feb; 42(2):166-9. PubMed ID: 2579626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemiballismus: changes in cerebrospinal fluid.
    Kostic V; Djuricic B; Paschen W
    Acta Neurol Scand; 1988 Aug; 78(2):115-7. PubMed ID: 2459894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of indices of central dopaminergic functions in man.
    Bagdy G; Arató M; Baraczka K; Fekete MI
    Life Sci; 1983 Jun; 32(23):2667-76. PubMed ID: 6855463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ontogeny of 3,4-dihydroxyphenylacetic acid in human cerebrospinal fluid.
    Anderson GM; Riddle MA; Hoder EL; Feibel FC; Shaywitz BA; Cohen DJ
    J Neurol Neurosurg Psychiatry; 1988 Aug; 51(8):1100-2. PubMed ID: 3216215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical aids in the diagnosis of Parkinson's disease.
    Chase TN; Eng N; Gordon EK
    Ann Clin Lab Sci; 1976; 6(1):4-10. PubMed ID: 1247283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine metabolites in human brain.
    Wilk S; Stanley M
    Psychopharmacology (Berl); 1978 Apr; 57(1):77-81. PubMed ID: 96472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) levels in human cerebrospinal fluid after L-dopa and deprenyl administration.
    Baraczka K; Fekete MI; Kanyicska B
    J Neural Transm; 1983; 58(3-4):299-304. PubMed ID: 6420516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of dopamine depletion and compensatory response in striatum and cerebrospinal fluid.
    Loeffler DA; LeWitt PA; DeMaggio AJ; Juneau PL; Milbury PE; Matson WR
    J Neural Transm Park Dis Dement Sect; 1995; 9(1):45-53. PubMed ID: 7605589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.